Loading…
CIK 0001917529 • 6 13F filings • May 14, 2025 – Aug 13, 2026
Import this data to Google Sheets with:
=jivedata("atlas-venture-life-science-advisors-llc","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| Day One Biopharmaceuticals, Inc. | Common Stock | $59.8M | 6.9%Prev: 6.0% | 6,412,560 SH | Increased-17,697 SH |
| Disc Medicine, Inc. | Common Stock | $120.2M | 13.9%Prev: 18.8% | 1,513,875 SH | Decreased-628,742 SH |
| Dyne Therapeutics, Inc. | Common Stock | $178.6M | 20.6%Prev: 15.3% | 9,130,465 SH | Increased |
| Generation Bio, Co. | Common Stock | $4.7M | 0.5%Prev: 0.7% | 827,946 SH | Decreased |
| Korro Bio, Inc. | Common Stock | $9.1M | 1.1%Prev: 7.2% | 1,137,149 SH | Decreased |
| Kymera Therapeutics, Inc. | Common Stock | $362.6M | 41.9%Prev: 36.8% | 4,659,874 SH | Increased-236,588 SH |
| Q32 Bio, Inc. | Common Stock | $6.9M | 0.8%Prev: 0.6% | 2,092,106 SH | Increased |
| Sionna Therapeutics, Inc. | Common Stock | $123.2M | 14.2%Prev: 14.1% | 2,995,602 SH | Increased-619,925 SH |
| 13F-HR |
| 0001104659-26-095933 |
| $881.3M |
| View |
| Aug 12, 2025 | Q2 2025 | 13F-HR | 0001104659-25-076898 | $662.4M | View |
| May 14, 2026 | Q1 2026 | 13F-HR | 0001104659-26-061232 | $790.0M | View |
| May 14, 2025 | Q1 2025 | 13F-HR | 0001104659-25-048527 | $521.8M | View |